Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06270043

Focal Therapy for Localized Prostate Cancer

A Prospective Registry and Longitudinal Study of Patients Undergoing Focal Therapy for Localized Prostate Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
University of California, San Diego · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

This prospective registry and longitudinal study that is designed to carefully measure details of prostate cancer patients' outcomes with focal therapy. The goal of which is to improve patient care.

Detailed description

This observational study will serve to collect data from medical record and review questionnaires before and after focal ablation of prostate tissue. All enrolled subjects will have already undergone or scheduled to receive the focal therapy as part of their prostate cancer treatment.

Conditions

Interventions

TypeNameDescription
PROCEDUREFocal TherapyFocal ablation of prostate cancer using different modalities. These modalities include: * Cryoablation or Cryotherapy * Irreversible Electroporation - Nanoknife * High Intensity Frequency Ultrasound - FocalOne * Transurethral Ultrasound Ablation - TULSA - PRO

Timeline

Start date
2024-02-01
Primary completion
2034-02-01
Completion
2034-02-01
First posted
2024-02-21
Last updated
2024-02-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06270043. Inclusion in this directory is not an endorsement.

Focal Therapy for Localized Prostate Cancer (NCT06270043) · Clinical Trials Directory